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TROSPA, an Ixodes scapularis
Receptor for Borrelia burgdorferi
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mouse (Nadelman and Wormser, 1998; Steere, 2001).
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2004). In addition, OspA has been shown to be essentialThe Lyme disease agent Borrelia burgdorferi naturally
persists in a cycle that primarily involves ticks and for B. burgdorferi to persist within the tick (Yang et al.,
2004). The targeted ablation of OspA in an infectiousmammals. We have now identified a tick receptor
(TROSPA) that is required for spirochetal colonization isolate of B. burgdorferi did not interfere with the spiro-
chete’s ability to infect and cause disease in mice, butof Ixodes scapularis. B. burgdorferi outer surface pro-
tein A, which is abundantly expressed on spirochetes the OspA-deficient spirochetes failed to colonize and
survive within I. scapularis—and, in particular, thesewithin the arthropod and essential for pathogen ad-
herence to the vector, specifically bound to TROSPA. B. burgdorferi could not bind to the tick gut (Yang et
al., 2004).TROSPA mRNA levels in ticks increased following
spirochete infestation and decreased in response to The vector ligands that participate in B. burgdorferi-
tick interactions have not yet been identified. Since theengorgement, events that are temporally linked to
B. burgdorferi entry into and egress from the vector. tick gut is the principal site where B. burgdorferi persist
in the vector, and the spirochetes almost exclusivelyThe blockade of TROSPA by TROSPA antisera or by
the repression of TROSPA expression via RNA interfer- reside within this tissue during the long intervals be-
tween the tick blood meals (de Silva and Fikrig, 1995),ence reduced B. burgdorferi adherence to the I. scapu-
laris gut in vivo, thereby preventing efficient coloniza- it is likely that B. burgdorferi has evolved mechanisms
to specifically interact with arthropod receptors withintion of the vector and subsequently reducing pathogen
transmission to the mammalian host. Identification of the gut. We have now characterized an I. scapularis
protein that binds to OspA and determined its impor-an I. scapularis receptor for B. burgdorferi is the first
step toward elucidating arthropod ligands that are re- tance in spirochete-vector interactions.
quired for survival of spirochetes in nature.
Results
Introduction
Cloning of the OspA Receptor within I. scapularis
In the United States, the life cycle of Borrelia burgdorferi, Since OspA binds to a protein receptor within the
the Lyme disease agent, primarily involves a tick, Ixodes I. scapularis gut (Pal et al., 2000), an I. scapularis cDNA
library was constructed in a yeast-Escherichia coli shut-
tle vector and screened using a LexA-OspA fusion pro-*Correspondence: erol.fikrig@yale.edu
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Figure 1. Cloning of TROSPA
Nucleotide and predicted amino acid sequences of TROSPA (accession number AY189148). The sequences were obtained from OspA
interactive yeast two-hybrid overlapping clones except for the first 29 nucleotides (indicated in small letters), which were derived from clones
obtained from 5 RACE and cDNA library screening. The in-frame putative TROSPA translational start codon, stop codon, and polyadenylation
signal are indicated in bold. A putative transmembrane domain and several O-glycosylation sites are indicated by shading and asterisks, respec-
tively.
tein as bait. We isolated three OspA interactive clones, randomized repeats of up to 17 residues with an unusu-
ally high number of potential posttranslational modifica-which represented overlapping sequences of one com-
mon tick cDNA, designated as the gene encoding the tion signals, including O-glycosylation sites such as Gal-
NAc motifs (n  38, threshold  0.5), O-()-GlcNActick receptor for OspA (TROSPA). The observed protein-
protein interaction was specific, as TROSPA did not motifs (n  27, threshold  0.5), and phosphorylation
sites (n 21, threshold 0.5) with a putative transmem-interact with control antigens such as LexA alone (with-
out any fusion partner) or a LexA-Lamin fusion protein brane helix between residues 6 and 40 (TMpred Predic-
tion) (Figure 1).in this yeast two-hybrid assay. The GC-rich TROSPA
sequence obtained from the two-hybrid screen con-
tained an open reading frame (ORF) of 617 nucleotides
Localization of TROSPA in the Tick Gutwith a 3-untranslated region that included a polyadenyl-
Since the initial TROSPA cDNA sequence encoded aation signal sequence. To define the full-length TROSPA
functional OspA binding protein, this cDNA was ex-mRNA, we performed 5 RACE (rapid amplification of
pressed in E. coli (Figure 2A, lane 1) and used as ancDNA ends) and direct screening of two different I. scap-
antigen to develop TROSPA antisera (Figure 2A, lane 2)ularis cDNA libraries with a TROSPA probe (see Experi-
for localization and functional studies. In Western blots,mental Procedures). Sequencing of isolated cDNA
the TROSPA antisera reacted with a tick gut protein thatclones from the 5 RACE or library screening yielded
migrated with an approximate molecular mass of 55an additional 29 upstream nucleotides beyond the 5
kDa, both in one- and two-dimensional gels (Figure 2B,terminus of the cDNA identified from the two-hybrid
lane 1 and 2C, left panel). TROSPA appeared to be gutscreen (Figure 1). To rule out the possibility that the
specific, as I. scapularis salivary gland lysates or hemo-5 RACE or cDNA library screening could not obtain
lymph proteins did not significantly react with TROSPAadditional TROSPA sequence due to the secondary
antisera (data not shown). Since TROSPA antisera raisedstructure of the highly GC-rich TROSPA mRNA, an
against the recombinant peptide recognized a 55 kDaI. scapularis genomic DNA library was constructed and
gut protein, we next examined whether the 55 kDa pro-probed with TROSPA cDNA. One phage clone contained
tein was native TROSPA and if the protein was post-a 20 Kb genomic DNA insert harboring the entire
translationally modified. Nymphal gut proteins wereTROSPA gene. Comparison of the genomic and cDNA
separated on a two-dimensional gel, and the TROSPAsequences identified the presence of three exons and
antisera-reactive 55 kDa tick protein was isolated andtwo introns within the TROSPA gene (accession number
digested in-gel with trypsin, followed by liquid chroma-AY640046). The genomic sequence had typical pro-
tography-mass spectrophotometry/mass spectropho-moter elements such as a TATA box (gTATAaaa) and
tometry (LC-MS/MS) analysis for identification of thetranscription factor recognition sequences either up-
charged TROSPA peptides (see Experimental Proce-stream of the TROSPA transcription initiation site at the
dures). As summarized in Supplemental Table S1 (at ht5 end of exon 1 or within intron 1 (data not shown).
tp://www.cell.com/cgi/content/full/119/4/457/DC1/),Nucleotide sequence analysis revealed that the full-
we consistently obtained a mass match for the triplylength TROSPA cDNA contained a KOZAK (Kozak, 1987)
charged TROSPA peptide (938.77) on the TROSPA anti-compatible ATG codon at position 164 at the 5 end,
sera-reactive 55 kDa gut protein, strongly suggestingwhich encoded a TROSPA protein with a predicted mo-
the presence of native TROSPA.lecular mass of 16.1 kDa. TROSPA nucleotide and pro-
Because of the higher molecular mass of nativetein sequences displayed no significant homologies to
TROSPA when compared to the recombinant peptidegenes in several databases (BLAST search, GenBank
sequence, we next determined whether TROSPA was aand EMBL nonredundant databases, October 2004). The
deduced TROSPA amino acid sequence had several glycoprotein. Treatment of gut proteins with a variety of
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Figure 2. Localization of TROSPA in the Tick Gut
(A) Production of recombinant TROSPA and recognition by TROSPA antisera. Expression of an OspA interactive yeast two-hybrid clone
(spanned from nucleotide 49 to 724 of TROSPA cDNA) in Escherichia coli and purification of TROSPA after cleavage of the GST fusion
partner (Coomassie blue staining, lane 1, arrow). Western blotting of TROSPA, as shown in lane 1, by a TROSPA antisera (lane 2) or control
GST antisera (lane 3) is shown. Glycosylated TROSPA (arrowhead) produced in Drosophila S2 cell detected with anti-V5 antibody (lane 4).
Glycosylated TROSPA (as shown in lane 4) was also strongly recognized by TROSPA antisera (data not shown).
(B) TROSPA antisera recognized a specific tick gut protein in the Western blot. Proteins in TGE were resolved into a 12% SDS-PAGE gel,
transferred onto nitrocellulose, and blotted with 1:1000 dilution of TROSPA antisera (lane 1) or controls: GST antisera (lane 2) and preimmune
sera (lane 3). The arrow indicates a tick protein of approximate molecular mass of 55 kDa that strongly reacted with TROSPA antisera.
Molecular mass markers (kDa) are indicated on the right.
(C) Recognition of the specific native 55 kDa tick gut protein (as shown in [B]) by TROSPA antisera in a two-dimensional gel (arrow, left panel).
The blot was reprobed with GST antisera, which do not recognize native TROSPA (arrow, right panel). Arrowhead indicates tick proteins
recognized by TROSPA as well as GST antisera. Molecular mass markers (kDa) are indicated on the left.
(D) Confocal immunofluorescence localization of native TROSPA in the I. scapularis gut. Binding of preimmune or TROSPA antisera was
detected using a FITC-labeled rabbit IgG; tick nuclei were stained with propidium iodide (red). TROSPA antisera reactive fluorescence (green)
was most prevalent in the tissue areas surrounding nuclei and on luminal surfaces (arrow). Images were examined using a Zeiss LSM 510
confocal 63 objective lens and presented as a single image for clarity.
(E) Colocalization of B. burgdorferi and TROSPA within the gut of an unfed nymphal I. scapularis. Spirochetes, OspA, and TROSPA were
detected using FITC-labeled anti-B. burgdorferi goat IgG, Alexa 568-labeled anti-mouse IgG, and Alexa 647-labeled anti-rabbit IgG, respectively.
Images were examined using the confocal 40 objective lens. Note attached spirochetes (green) producing OspA (red) within tick gut cells
expressing TROSPA (blue).
glycosidases reduced the level of TROSPA antisera- a glycoprotein detection kit based on Periodic Acid-
Schiff method, thereby demonstrating that TROSPA un-reactive 55 kDa gut protein when compared to untreated
controls. However, the antisera failed to recognize any dergoes glycosylation in arthropods (see Supplemental
Figure S1A on the Cell web site). Confocal immunofluo-protein of smaller molecular mass, suggesting that de-
glycosylated TROSPA is unstable in ticks (data not rescence studies showed TROSPA labeling on the sur-
face of Drosophila cells, indicating that the protein wasshown). When we expressed recombinant TROSPA in
a Drosophila cell line, we found that TROSPA was post- predominantly associated with the plasma membrane
of transfected cells (Supplemental Figure S1B).translationally modified in arthropods (Figure 2A, lane
4). Unlike recombinant TROSPA produced in E. coli, Immunolocalization studies using confocal micros-
copy confirmed that TROSPA antisera reacted stronglyDrosophila-expressed TROSPA selectively reacted with
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Figure 3. Immunogold Localization of Native TROSPA and B. burgdorferi within I. scapularis Gut
Bb, Borrelia burgdorferi; BL, basal lamina; Cy, cytoplasm; H, hemocoel side; L, lumen; M, mitochondria; N, nucleus. Short arrows point to
convoluted epithelial plasma membranes of adjacent cells forming tight junctions. Luminal microvilli are indicated by arrowheads. Scale bar,
500 nm.
(A) A low-power electron micrograph of the morphology of the unfed I. scapularis nymphal gut. Note high convolution of plasma membranes
toward a narrow lumen. Inset shows 2-fold magnification of the luminal area indicated by a box.
(B) A section of gut stained with preimmune sera. Note the absence of gold particles, indicating that preimmune sera does not recognize an
antigen in the I. scapularis gut.
(C) Localization of gold particles indicating existence of native TROSPA (thin arrows) along the junction of plasma membranes (short arrow)
of epithelial cells. Some gold particles were also detected within the cytoplasm and luminal microvilli.
(D) A low-power electron micrograph showing attached B. burgdorferi to the gut microvilli in a partially fed (48 hr) I. scapularis nymphal gut.
(E) Colocalization of B. burgdorferi and TROSPA within tick gut. Magnified view of the attachment site of B. burgdorferi (area indicated by
box in [D]) to the microvilli of tick gut epithelial cells expressing TROSPA. Spirochetes were labeled with antisera raised against whole
B. burgdorferi N40 (small, 5 nm gold particles, asterisk). TROSPA was detected using a rabbit TROSPA antisera (larger, 10 nm gold particles,
thin arrows).
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with the gut tissue of I. scapularis nymphs—TROSPA (pI 4.7/16 kDa), Salp25D (pI 5.7/25 kDa), and Salp15 (pI
9.7, 14.7 kDa) (Das et al., 2001). B. burgdorferi OspB iswas predominantly localized in the intercellular spaces
and luminal surface of the gut (Figure 2D). We further 53% identical and 63% similar to OspA and also ex-
pressed within ticks; however, FITC-labeled OspB didstudied the distribution of TROSPA and B. burgdorferi
within the infected tick gut. B. burgdorferi produce OspA not bind to TROSPA (data not shown). Competition
assays further demonstrated the specificity of the OspA-in the vector, and immunofluorescence studies using
TROSPA and OspA antibodies demonstrated colocali- TROSPA interaction. Unlabeled OspA significantly inhib-
ited the binding of labeled OspA to TROSPA in a concen-zation of B. burgdorferi and TROSPA within the tick gut
(Figure 2E). We next used immunoelectron microscopy tration-dependent fashion (p  0.01, Figure 4B). Finally,
either pretreatment of immobilized tick gut extracts pre-to examine the precise subcellular localization of
TROSPA within the I. scapularis gut. The gut is mostly pared from nymphal I. scapularis with antisera to
TROSPA or preincubation of labeled OspA with recom-comprised of one to three tiers of epithelial cells resting
on a thick basal lamina and the epithelial membrane binant TROSPA both significantly (p  0.01) inhibited
binding of labeled OspA to nymphal tick gut lysatestoward the apical surface project short microvilli inter-
digitating in a narrow lumen (Figure 3A). The adjacent (Figure 4C).
In the second series of assays, we tested the bindingcells are separated by a highly folded plasma membrane
forming “tight junctions” (short arrows, Figure 3A–3C), of soluble TROSPA to immobilized spirochetes. B. burg-
dorferi lysates (Figure 4D) or intact unfixed B. burgdorf-which maintain the integrity of the gut epithelial barrier
between cells (Sauer and Hair, 1986; Sonenshine, 1993). eri (Figures 4E and 4F) were immobilized on microtiter
wells or glass slides, respectively, and incubated withIn the I. scapularis gut, we detected heavy labeling of
TROSPA along such tight junctions (579  110 gold TROSPA. Binding of TROSPA to B. burgdorferi was de-
tected using antisera against TROSPA. TROSPA specifi-particles/	m2) (Figure 3C). Organelle structures resem-
bling Golgi bodies or endoplasmic reticulum were not cally bound to OspA-producing B. burgdorferi lysates
(Figure 4D) or to intact spirochetes (Figure 4E). Markedlyobvious within the cells; however, we detected a low
level of TROSPA labeling within the cytoplasm (36  13 less binding of TROSPA to the OspA-deficient B. burg-
dorferi was noted when compared to OspA-expressinggold particles/	m2) or within microvilli (115  48 gold
particles/	m2) (Figure 3C). Negligible labeling (1 gold B. burgdorferi (Figures 4D and 4F). Additionally, an OspA
antibody also inhibited the binding of TROSPA to wild-particles/	m2) was noted in cytoplasmic organelles such
as the mitochondria, lysosomes, and residual bodies or type B. burgdorferi (Figure 4D). B. burgdorferi FlaB anti-
body (Pal et al., 2000) did not significantly inhibit thewithin the nucleus. As expected, preimmune rabbit sera
(control) did not show significant reactivity to tick gut binding of TROSPA to wild-type B. burgdorferi (data not
shown). Taken together, these experiments demon-epithelial cells (1 gold particles/	m2) (Figure 3B). Colo-
calization of B. burgdorferi and TROSPA using immu- strate the specificity of the TROSPA-OspA interaction.
noelectron microscopy indicated specific TROSPA la-
beling within the tick gut where spirochetes are closely Expression of TROSPA within Ticks
associated with the luminal microvilli (Figures 3D and We then determined whether TROSPA was regulated
3E). Some TROSPA labeling was also detected on the during tick development, feeding, or B. burgdorferi in-
surface of the bacterium, suggesting the presence of festation. To measure the levels of TROSPA mRNA dur-
the soluble form of TROSPA in ticks (Figure 3E). ing tick development, quantitative RT-PCR was per-
formed using -actin as an internal control (Figure 5A).
TROSPA was highly expressed in immature stages ofOspA Specifically Binds to Recombinant TROSPA
We next assessed whether TROSPA binds to OspA by ticks such as larva (7.5  0.2 fg/	g total RNA) and
nymphs (3.0 0.5 fg/	g total RNA). TROSPA expressionperforming a series of in vitro binding assays. The first
set of assays evaluated the interaction between was detectable in adults (0.21  0.03 fg/	g total RNA);
however, the level was significantly lower than that inTROSPA and recombinant OspA (Figures 4A–4C). La-
beled OspA specifically bound to both recombinant larva or nymphs (p  0.01) (Figure 5A).
To correlate TROSPA expression in ticks to B. burg-TROSPA as well as native protein(s) in nymphal I. scapu-
laris gut extracts (Figure 4A). Binding kinetics of a fixed dorferi binding within the tick gut, we next studied
whether a lower level of TROSPA within adult ticks alsoconcentration of OspA with increasing amounts of
TROSPA demonstrated that the OspA-TROSPA binding resulted in their diminished capacity to bind OspA or
the OspA-producing intact bacteria. We used equalwas saturable (Supplemental Figure S2). An indepen-
dent, surface plasmon resonance (SPR)-based assay amounts of prepared gut lysates from nymphal and adult
ticks to assess the binding of OspA or B. burgdorferi.further demonstrated high affinity of OspA-TROSPA in-
teraction with a calculated Kd of 42.6 16.3 nM (Supple- The decreased level of TROSPA mRNA in adults (Figure
5A) correlated with diminished binding of OspA or OspA-mental Figure S3). OspA did not bind to control proteins
including maltose binding protein, bovine serum albu- producing intact B. burgdorferi to the gut lysates from
adult ticks in comparison to nymphs (p 0.01, Figure 5B).min, or other recombinant I. scapularis proteins such as
Salp16 or Salp15, which are expressed selectively in the Before migrating to mammals, B. burgdorferi spend
long intervals in the gut of unfed I. scapularis nymphs.salivary glands (Das et al., 2001); or Salp25D, which is
expressed in both the salivary glands (Das et al., 2001) Therefore, we tested the possibility that B. burgdorferi
influences TROSPA expression, as it could be advanta-and gut (our unpublished data) (Figure 4A). Recombinant
I. scapularis proteins used in the assay covered a wide geous for the spirochete to induce the tick to produce
abundant TROSPA. We performed quantitative RT-PCRrange of charges and molecular masses such as Salp16
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Figure 4. Interaction between OspA and TROSPA In Vitro
Bars represent mean  SE from three experiments. (A) OspA directly binds to TROSPA. Bovine serum albumin (BSA); recombinant maltose
binding protein (MBP); recombinant tick proteins Salp16, Salp15 and Salp25D; tick gut extracts (TGE); or recombinant TROSPA were immobilized
onto microtiter wells (5 	g/ml), probed with FITC-labeled OspA, and recognized by HRP-labeled anti-FITC IgG. Difference between TROSPA
or TGE with controls was significant, p  0.01. (B) Inhibition of the OspA-TROSPA interaction using increasing amounts of unlabeled OspA
as competitor. Recombinant TROSPA were immobilized onto microtiter wells (150 ng/well) and probed with FITC-labeled OspA (1 	g/well) in
the absence (bar marked 0) or presence of increasing amounts (0.5–25 	g/well) of unlabeled OspA (black bars) or a control B. burgdorferi
outer surface protein, BmpA (pI 5.2/36.9 kDa) (gray bars). Unlabeled OspA significantly inhibited the binding of labeled OspA to TROSPA at
all concentrations used (p  0.01 or lower) in comparison to BmpA, which was unable to inhibit the binding. A similar result was also obtained
when BSA was used as a control competitor instead of BmpA (data not shown). Background binding of FITC-labeled OspA to PBS-coated
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on equal amounts of cDNA prepared from B. burgdorf- no significant alterations in gut morphology were ob-
served by confocal microscopy of nymphs treated witheri-infested or naive I. scapularis nymphs. We detected
preimmune or TROSPA antisera.a significant increase in TROSPA transcripts in infected
While the number of spirochetes, which arrived in thecompared to uninfected ticks (p  0.03, Figure 5C).
tick gut, was not affected by the presence of TROSPAThe increase in TROSPA mRNA was attributed to the
antisera, we did detect a significant difference in B.presence of viable spirochetes as confirmed by the detec-
burgdorferi numbers that were tightly associated withtion of B. burgdorferi ospA and flaB mRNAs by RT-PCR.
the gut tissue. The role of TROSPA antisera in B. burg-Gut epithelial cells of infected or naive ticks were similar
dorferi adherence to the tick gut was examined at 24,in number and structure (data not shown), suggesting
48, 72, and 96 hr after feeding in engorged ticks thatthat the observed difference in TROSPA transcripts was
had fed on mice treated with control or TROSPA anti-due to the presence of the spirochetes.
sera. Gut tissue was washed free of luminal contents orWe next studied expression of TROSPA during tick
unbound spirochetes and assessed by immunofluores-feeding using cDNA prepared from unfed or fully en-
cence confocal microscopy. A large number of B. burg-gorged nymphs. We detected a significant decrease
dorferi in the control groups (preimmune serum) was(p  0.01) in the amount of TROSPA mRNA in nymphal
found in close proximity to the gut luminal tissue (Figureticks after feeding (Figure 5C). Since we found a down-
6A, left panel). In contrast, TROSPA antisera-treatedregulation of TROSPA during tick feeding, as opposed
samples had very few spirochetes associated with theto a TROSPA upregulation in unfed ticks by spirochetes
gut at 48 hr (Figure 6A, right panel, and Figure 6B, p (Figure 5C), we assessed whether TROSPA mRNA levels
0.001). This reduction in spirochete numbers in TROSPAwere affected in ticks feeding on spirochete-infected or
antisera-treated samples was noted at all time pointsnaive mice. TROSPA mRNA levels in these fed nymphs
analyzed (data not shown). This observed reduction in B.showed no significant differences (data not shown),
burgdorferi number in antisera-treated ticks was furtherdemonstrating that downregulation of TROSPA during
evaluated by RT-PCR analyses of ospA and flaB tran-feeding is not influenced by spirochete infection.
scripts for detection of viable spirochetes, either from
fed larval (data not shown) or nymphal ticks (Figure 6C),
TROSPA Antibodies Interfere with Tick- after seven days of engorgement. Significantly lower
B. burgdorferi Interactions numbers of viable spirochetes were evident in the
We then examined the biological significance of the TROSPA antisera-treated group. Results similar to those
OspA-TROSPA interaction using a murine model of shown in Figures 6A and 6B were obtained when some of
Lyme borreliosis to determine whether TROSPA antisera the larvae and nymphs from the preimmune or TROSPA
could influence the colonization of the I. scapularis gut antisera-treated group were allowed to molt into
in vivo by B. burgdorferi. Groups of five C3H mice were nymphs or adults respectively and then analyzed by
intradermally challenged with B. burgdorferi N40 (105 confocal microscopy and RT-PCR.
spirochetes/mouse). At 3 weeks, all the mice had swell- We next assessed whether diminished spirochete col-
ing of the tibiotarsal joints, and spirochete infection was onization of the tick gut in the TROSPA antisera-treated
confirmed by culture. TROSPA antisera or preimmune group (Figures 6A and 6B) also resulted in a decreased
rabbit sera (control) was administered to different groups capacity to transmit infection to naive mice. TROSPA
of animals. Twenty-four hours later, ten uninfected antisera or preimmune rabbit sera (control) were pas-
I. scapularis nymphs or 20 larvae were allowed to feed sively transferred into groups of five C3H mice that had
to repletion on each mouse. The engorged ticks were been infected with B. burgdorferi N40 (105 spirochetes/
dissected, and the luminal contents were examined for mouse) for 3 weeks. Larval ticks (50 ticks/group) were
B. burgdorferi. Equal numbers of viable spirochetes allowed to feed to repletion on these mice and kept in the
were detected in preimmune or TROSPA antisera- laboratory to molt into nymphs. Newly molted nymphs
treated groups, suggesting that TROSPA antisera treat- (from the TROSPA antisera- or control sera-treated,
ment did not interfere with the migration of B. burgdorf- three ticks/group) were then allowed to feed to repletion
eri into the tick gut (data not shown). While TROSPA on groups of naive C3H mice. Murine skin samples were
collected 3 days following tick feeding and assessedantisera reacted with the luminal surface of the fed gut,
wells (white bar marked B) is indicated. (C) TROSPA antisera or recombinant TROSPA protein interferes with OspA binding to native protein(s)
in TGE. Microtiter wells were coated with TGE and probed with FITC-labeled OspA in the absence (bar marked TGE) or presence of competitors
including preimmune sera (TGE  Preimmune), TROSPA antisera (TGE  Anti-TROSPA), BSA (TGE  BSA), recombinant TROSPA (TGE 
TROSPA). Background binding of FITC-labeled OspA to BSA-coated wells (bar marked BSA) is also shown. p  0.001 between TGE and
(TGE  Anti-TROSPA), p  0.007 between TGE and (TGE  TROSPA), whereas difference between TGE and controls (TGE  Preimmune or
TGE  BSA) is insignificant, p  0.05. (D) TROSPA binding is specific to B. burgdorferi. Soluble proteins from wild-type B. burgdorferi (black
bar), an OspA-deficient B. burgdorferi (gray bar), or BSA (white bar) were coated onto microtiter wells. Bound TROSPA was detected using
TROSPA antisera (
-TROSPA) or normal rabbit sera (NRS) followed by HRP-conjugated secondary antibody. Specificity of binding was tested
by addition (indicated by ) or absence (indicated by ) of TROSPA protein, OspA antibody (
-OspA), or TROSPA antiserum. *, difference
(first bar) with controls (bars 2–7) is significant, p  0.002. (E) TROSPA directly binds to the surface of intact B. burgdorferi. Unfixed B.
burgdorferi were immobilized onto glass slides and incubated in the presence or absence of recombinant TROSPA. Binding was detected
using TROSPA antisera or normal rabbit sera (NRS) followed by incubation with anti-rabbit IgG-FITC. Samples were counterstained with
propidium iodide (left panels) to visualize spirochetes. Images were collected using a 40 objective lens on the confocal microscope. (F)
TROSPA binds poorly to the surface of intact OspA-deficient B. burgdorferi. Unfixed B. burgdorferi were immobilized onto glass slides,
incubated with TROSPA, and processed similarly as described in (E).
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for B. burgdorferi transmission by quantitative PCR.
TROSPA antisera significantly reduced (approximately
75%) the migration of spirochete into mice, indicating
that diminished colonization of the tick gut reduced the
number of spirochetes that were transmitted to the
mammalian host (Figure 6D, p  0.001). B. burgdorferi
begin to multiply once they reach murine skin (Mala-
wista, 2000; Nadelman and Wormser, 1998; Steere et
al., 2004), and viable spirochetes were recovered from
murine skin samples at 2 weeks following tick feeding.
TROSPA-Deficient Ticks Have Reduced
B. burgdorferi Colonization
To confirm the role of TROSPA in mediating B. burgdorf-
eri colonization within the tick gut, we generated
TROSPA-deficient nymphal ticks using RNA interfer-
ence (RNAi) (see Experimental Procedures). TROSPA
dsRNA and salp15 (Das et al., 2001) dsRNA were synthe-
sized in vitro. salp15 was chosen as a control for the
TROSPA RNAi studies because it is a well-characterized
I. scapularis gene (Das et al., 2001). Injection of salp15
dsRNA results in downregulation of salp15, which, how-
ever, does not interfere with the tick feeding (data not
shown). Equal volumes of the respective dsRNA or
buffer were delivered directly into the gut of naive Ixodes
nymphs (50 ticks/group) via microinjection (Pal et al.,
2004). Ticks were allowed to rest for 3 hr and placed on
C3H mice (three mice/group) that were infected with B.
burgdorferi N40 (105 spirochetes/mouse) for 3 weeks.
At 48 hr following the onset of feeding, RT-PCR or West-
ern blot assessment indicated a dramatic reduction in
the levels of TROSPA mRNA and protein (Figures 6E
and 6F) within TROSPA dsRNA-treated tick guts, com-
pared to salp15 dsRNA-treated or buffer-treated groups.
In contrast, both the mRNA and protein levels of two
control genes—actin (Figures 6E and 6F) and salp25D
(data not shown)—remained unaltered in both dsRNA-
and buffer-treated groups.
We then assessed whether colonization of spiro-
chetes was affected by RNAi-mediated TROSPA defi-
ciency. Guts isolated from TROSPA dsRNA, salp15
dsRNA, or buffer-treated ticks were assessed for spiro-
chete-tick gut associations as described above (Figure
6A). A significant reduction in the number of B. burgdorf-
eri closely associated with the gut was noted in TROSPA
dsRNA-treated ticks (Figures 6G and 6H, p  0.001),
as compared to salp15 dsRNA or buffer-treated ticks
confirming a definitive role for TROSPA in facilitating
colonization of the tick gut by spirochetes.
Figure 5. Expression of TROSPA within I. scapularis
Bars represent mean  SE from three experiments. (A) TROSPA is
B. burgdorferi binding capacity of adult guts. Background bindingdownregulated during the development of I. scapularis. Total RNA
of OspA or B. burgdorferi to FCS (control) is also shown (B). Bindingwas prepared from larva (n  100), nymph (n  25), or adults (n 
of nymphs to OspA or B. burgdorferi was considered as a 100%10), and amounts of TROSPA were measured by quantitative PCR.
value. Differences of OspA or B. burgdorferi binding betweenDifferences between TROSPA amounts in larva or nymph with adult
nymphs and adults are significant, p 0.01. (C) TROSPA expressionis significant, p  0.01. (B) Expression of TROSPA correlated with
is altered in different physiological states of nymphal I. scapularis.B. burgdorferi OspA or intact B. burgdorferi binding to the tick gut.
The presence of B. burgdorferi within unfed I. scapularis enhancedLysates from adult (n 10) or nymphal guts (n 50) were prepared,
the amount of TROSPA transcripts (p  0.03), whereas the amountand equal amount of protein was used to assess binding of FITC-
of TROSPA RNA decreased during tick feeding (p  0.01). Totallabeled OspA (black bars) or intact spirochetes (white bars). Bound
RNA was prepared from naive (n  100), B. burgdorferi-infestedOspA was measured using a HRP-labeled anti-FITC IgG, whereas
(n  100), or fed nymphs (n  25) and assessed by quantitative RT-bound B. burgdorferi were detected using a rabbit antiserum raised
PCR. Amount of TROSPA transcripts within unfed naive nymphsagainst B. burgdorferi and HRP-labeled anti-rabbit IgG. Low
was considered as the 100% value.TROSPA expression in adult ticks (A) is reflected in low OspA and
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Discussion We finally evaluated whether blocking of TROSPA
within I. scapularis interferes with the life cycle of B.
Tissue adherence capabilities of pathogenic bacteria burgdorferi. In vivo studies using a murine model of
are essential for their survival and persistence within Lyme borreliosis show that TROSPA antisera signifi-
host tissues (Finlay and Cossart, 1997). B. burgdorferi cantly reduced the ability of spirochetes to colonize both
prominently produce OspA within the vector (de Silva larval and nymphal I. scapularis. Fewer B. burgdorferi
et al., 1996; Schwan and Piesman, 2000), OspA mediates persisted throughout the postfeeding phases in anti-
spirochete-I. scapularis adherence (Pal et al., 2000), and sera-treated groups, and these spirochetes had a dimin-
the targeted ablation of OspA prevents B. burgdorferi ished capability to be transmitted to a new host. These
colonization of ticks in vivo, highlighting the importance findings demonstrate that TROSPA-based tissue coloni-
of OspA-based binding of the spirochetes to the I. scap- zation is an essential prerequisite for B. burgdorferi to
ularis gut (Pal et al., 2001; Yang et al., 2004). It is likely persistently infect ticks and for their subsequent migra-
that this event involves both vector and pathogen gene tion to new host. A similar result was obtained in RNAi
products (Munderloh and Kurtti, 1995). In the present studies where we have shown that selective knock down
study, we have identified an arthropod receptor, of TROSPA directly interferes with colonization of spiro-
TROSPA, that is required for the successful colonization chetes within the tick gut. We noted no significant
of ticks by spirochetes. changes in gut morphology, feeding behavior, or molting
Several lines of evidence demonstrate that I. scapu- of ticks treated either with TROSPA antisera or TROSPA
laris TROSPA is a specific ligand for B. burgdorferi dsRNA, suggesting that the effects of the dsRNA or
OspA. The OspA-TROSPA interaction suggested by the antisera on colonization were not due to indirect effects
yeast two-hybrid screen was directly confirmed in a on tick biology but directly through TROSPA-OspA inter-
series of in vitro assays where OspA selectively bound action. A small proportion of spirochetes, however, were
TROSPA but not to other tick proteins. TROSPA antisera still able to colonize, persist, and then be transmitted
interfered with OspA binding to native tick gut proteins; to a naive host, indicating that TROSPA may not be the
however, partial inhibition of this attachment indicated only ligand utilized by spirochete in ticks.
that other pathways might also exist (Figure 4B). Recom- In summary, we present here direct evidence for the
binant TROSPA also directly adhered to the B. burgdorf- existence of a vector molecule, which is actively in-
eri surface or whole-cell lysates, and an OspA antibody volved in spirochete colonization and persistence within
inhibited this interaction. Finally, compared to OspA- ticks. Many arthropod-borne pathogens follow a com-
producing wild-type spirochetes, TROSPA bound poorly plex enzootic life cycle involving a wide variety of hosts,
to OspA-deficient B. burgdorferi. which is mediated, at least partly, by expression of a
The natural cycle of the Lyme disease spirochete re- distinct set of receptors in different tissue environments.
flects concomitant temporal expression of ospA and Identification of TROSPA as an important ligand at the
TROSPA. Inside ticks, B. burgdorferi copiously express B. burgdorferi-tick gut interface establishes a paradigm
ospA (de Silva et al., 1996; Schwan and Piesman, 2000), for exploring how these interactions support long-term
and, at the same time, I. scapularis express abundant persistence of pathogens within the vector. In nature,
TROSPA. Following tick engorgement, TROSPA expres- large numbers of human pathogens persist within selec-
sion decreases, paralleling the downregulation of ospA tive arthropod vectors. Understanding the fine molecu-
by B. burgdorferi. Both these changes may help spiro- lar details of vector-pathogen interactions will lead to the
chete detachment from the gut for transmission to a development of novel therapeutic or vaccine strategies
new host (de Silva et al., 1996; Schwan and Piesman, that can be rationally designed to target the pathogen
2000). In nature, spirochete colonization of immature life cycle within the arthropod host.
stages of I. scapularis is essential for the continuity of
the B. burgdorferi life cycle in mice and ticks. In contrast,
Experimental Procedures
although adult ticks are colonized by spirochetes, they
do not feed upon mice or participate in the perpetuation Ticks, Bacteria, and Mice
of the B. burgdorferi-mouse life cycle (Nadelman and The ticks used in this study originated from adult female I. scapularis
ticks collected in the field. Development and rearing of variousWormser, 1998; Steere, 2001). Adult I. scapularis ex-
stages of ticks were performed in the laboratory as described (Palpressed significantly less TROSPA than larvae or
et al., 2000). A low-passage (passage 3) virulent clonal isolate of B.nymphs and bound less B. burgdorferi in vitro than
burgdorferi N40 was used throughout (Pal et al., 2000); in vitronymphs, suggesting that either a lower level of TROSPA
binding assays also employed an OspA-deficient B. burgdorferi
is sufficient for adults to maintain B. burgdorferi or low (Yang et al., 2004). Six- to eight-week-old C3H/HeN mice were pur-
TROSPA levels in adults could be compensated by other chased from the National Institutes of Health.
binding pathways.
Although B. burgdorferi spends a significant amount Construction of Tick cDNA and Genomic DNA Libraries
of time inside I. scapularis, the spirochetes have not Tick RNA (400	g) was isolated from 5000 unfed I. scapularis nymphs
previously been shown to influence the vector. We there- using an RNA isolation kit (Clontech) and used to construct an I.
scapularis cDNA plasmid library into the EcoRI and NotI cloning sitefore determined whether B. burgdorferi altered I. scapu-
of the yeast-E. coli shuttle vector pYESTrp2 (prepared by Researchlaris gene expression. Most interestingly, we observed
Genetics-Invitrogen). The library had a titer of 1  106 cfu/100 ng,a significant increase in the expression of TROSPA when
and over 90% of the clones contain inserts that range from 0.5 to
I. scapularis were infested with spirochetes compared 4 kb. Known tick genes such as salp15, salp16, salp25D (Das et al.,
to ticks that did not harbor B. burgdorferi. TROSPA 2001), and -actin (Pal et al., 2004) were readily amplified from the
upregulation could potentially increase the OspA-TROSPA- library by PCR.
An I. scapularis genomic DNA library was prepared in a lambdamediated colonization of ticks by B. burgdorferi.
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Figure 6. TROSPA Antisera and TROSPA dsRNA Interfered with the Colonization of B. burgdorferi within I. scapularis and Transmission to
Murine Host
(A) TROSPA antisera interfere with the colonization of B. burgdorferi within the tick gut. Nymphal ticks were allowed to engorge on B.
burgdorferi-infected mice that had been treated with TROSPA antisera or preimmune sera (control). Guts were analyzed by confocal microscopy
at 48 hr post feeding. The spirochetes (arrow) were stained with a FITC-labeled goat anti-B. burgdorferi antibody (green), and the nuclei of
the tick gut epithelial cells were stained with propidium iodide (red). Images were examined using the confocal 40 objective lens and
presented as a single image for clarity. Data are the representation of three independent experiments.
(B) Quantitative assessment (relative number of B. burgdorferi) of the data presented in (A). Groups of five mice were infected with B. burgdorferi
before administration of either preimmune or TROSPA antisera at 24 hr before tick placement (ten nymphs/mouse). Engorged ticks were
examined at 48 hr after detachment using confocal microscopy to enumerate B. burgdorferi in direct contact with tick gut tissue. In each
experiment, the entire gut diverticulum was examined, and counts were made from at least three fields from two separate gut diverticula.
The average number of microscopic fields/diverticula was six; range, two to seven fields/diverticulum. Data are the number of spirochetes
per field from three independent experiments (mean  SE). Differences between preimmune- and TROSPA antisera-treated groups were
highly significant (p  0.001). Numbers of B. burgdorferi in preimmune sera-treated group (control) were considered as a 100% value.
(C) Detection of B. burgdorferi mRNA within engorged I. scapularis. TROSPA antisera or preimmune sera-treated nymphs (as described in
[A]) were analyzed at 7 days post feeding by RT-PCR using flaB or ospA primers for the detection of viable B. burgdorferi. I. scapularis -actin
was used as a control to ensure the equal loading of RNA. An aliquot of prepared RNA from each group was subjected to RT-PCR in the
absence of reverse transcriptase to ensure the absence of genomic DNA (data not shown).
(D) TROSPA antisera dramatically reduced the transmission of B. burgdorferi to mice. Larval ticks were allowed to feed to repletion on B.
burgdorferi-infected groups of three mice (50 ticks/mouse) (similar to [A]) that had been treated with TROSPA antisera or preimmune sera
(control) and allowed to molt into nymphs. Antisera-treated newly molted nymphs were allowed to engorge on groups of three naive mice
(three ticks/mouse), and murine skin samples were assessed for spirochete transmission after 3 days of feeding. DNA was isolated from skin
samples of different groups of mice, and B. burgdorferi flaB was measured using quantitative PCR. Data are the number of spirochetes per
field from two independent experiments (mean  SE). Difference in the spirochete transmission in TROSPA antisera-treated group with the
control is highly significant (p  0.001). B. burgdorferi flaB copy numbers in preimmune sera-treated group (control) was considered as a
100% value.
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Fix II vector (Stratagene), which accepts DNA inserts ranging from rabbit GST antisera (Amersham-Pharmacia Biotech), murine or rab-
bit preimmune or TROSPA antisera, guinea pig anti-Salp25D (Das9 to 23 Kb. DNA (200 	g) isolated from nymphal ticks, partially
digested with Sau3AI, filled on and cloned in the XhoI half site arms et al., 2001), or actin antisera (Sigma). Production of TROSPA in
Drosophila S2 cell line was also detected using an HRP-conjugatedof the vector. The ligated DNA was packaged into phage as per the
manufacturer’s instructions and stored at70C. The primary library anti-V5 antibody (Invitrogen). In some experiments, tick gut lysates
were treated with a variety of glycosidases as detailed (Pal et al.,had 1.4 106 recombinant clones, and 97% of the phages contained
an insert. 2000), and Western blotting was performed with TROSPA antisera
as described above.
Yeast Two-Hybrid Screening
The I. scapularis cDNA library constructed in a yeast-Escherichia Two-Dimensional Gel Electrophoresis and Mass
Spectrophotometrycoli shuttle vector was screened using a LexA-OspA fusion protein
as the bait as detailed in the Supplemental Experimental Proce- The total gut proteins (100 	g) were resolved by two parallel two-
dimensional SDS-PAGE gels (2D gel). The 2D gel was comprised ofdures.
a nonlinear immobilized pH 3–10 gradient in the first dimension
and 12% gel in the second dimension. Proteins from one gel wereSequence Analysis
The cDNA sequences were obtained by the dye terminator sequenc- transferred electrophoretically onto polyvinylene difluoride mem-
branes, which were probed with TROSPA antisera. The same blotsing method performed at the HHMI Biopolymer and W.M. Keck
Biotechnology Resource Laboratory at Yale University. Database were stripped and reprobed with GST antisera (control) to identify
nonspecific hybridization. We contemplated that TROSPA antiserasearches were made using WWW BLAST server in NCBI and EMBL.
Sequence analysis was performed using ExPASY proteomics tools might contain a small amount of IgG directed toward GST, since
trace amounts of GST could copurify with TROSPA used as antigen(www.expasy.ch/tools) as well as Lasergene software (DNAstar).
to raise antisera in rabbits. TROSPA immunoreactive proteins were
detected by HRP-conjugated secondary antibody on an autoradiog-Rapid Amplification of cDNA Ends
Amplification of 5 upstream of yeast two-hybrid TROSPA cDNA raphy film. The film was overlaid on the second 2D gel; the anti-
TROSPA immunoreactive gel spot was isolated and characterizedwas performed using either a SMART (switching mechanisms at 5
end of RNA transcript, Clontech) or RLM (RNA ligase-mediated, by tryptic peptide mass fingerprinting using LC-MS/MS analysis on
a Waters Q-Tof API Mass Spectrometer at the HHMI BiopolymerAmbion) RACE procedures. RNA (10 	g of total) was isolated from
I. scapularis nymphs and used in RACE reactions according to the and W.M. Keck Biotechnology Resource Laboratory at Yale.
manufacturer’s instruction with the following TROSPA specific re-
verse primers: 5-GACAACTGGAGCGGCAGCGACAGCGA-3, 5- Confocal and Immunoelectron Microscopy
Organs from nymphal ticks were prepared for confocal (Pal et al.,TGTAGCTGGAGCTGACGATTC-3, and 5-TGGTGTAGCTGGAGCT-
3. Amplified RACE products were subcloned into pCR 2.1 vector 2001) and immunoelectron microscopy (Folsch et al., 2001) as de-
tailed in the Supplemental Experimental Procedures.(Invitrogen) and sequenced.
Hybridization Screening of I. scapularis cDNA and Genomic In Vitro Binding Studies: Microtiter Assay,
Immunoflorescence, and SurfaceDNA Libraries
We screened the tick genomic DNA library, the pYESTrp2 cDNA Plasmon Resonance
In vitro binding of tick gut lysates or recombinant TROSPA withlibrary, and an additional 48 hr fed nymphal I. scapularis cDNA library
made in the phagemid vector pBK-CMV (Stratagene) constructed OspA as well as TROSPA binding to B. burgdorferi was performed as
described (Pal et al., 2000) and further detailed in the Supplementalin the laboratory of Aravinda de Silva. The libraries were screened
with a 689 bp TROSPA cDNA probe using Gene Image and CDP- Experimental Procedures.
Star kit as described in the manufacturer’s protocol (Amersham-
Pharmacia Biotech). PCR
RT-PCR and quantitative PCR analysis of I. scapularis TROSPA or
-actin, B. burgdorferi flagellin (flaB) or ospA, and murine -actinProtein Expression and Preparation of Polyclonal Antibody
Production of recombinant TROSPA in E. coli and Drosophila S2 was performed as detailed in the Supplemental Experimental Proce-
dures.cells and generation of polyclonal antibodies are detailed in the
Supplemental Experimental Procedures.
Passive Transfer of TROSPA Antisera and In Vivo
Adherence StudiesWestern Blotting
Western blotting was performed as described (Pal et al., 2001) using Antisera transfer and in vivo adherence studies were performed as
detailed before (Pal et al., 2001; Yang et al., 2004). Briefly, C3H mice1:500–5000 dilution of either of the following primary antibodies:
(E) Silencing of TROSPA transcripts induced by RNA interference. Data are the representation of three independent experiments. Nymphal
ticks (50 ticks/group) were injected with TROSPA dsRNA (TROSPA ds), salp15 dsRNA (salp15 ds), or buffer alone (buffer) and fed onto B.
burgdorferi-infected mice for 48 hr, and isolated guts were assessed by RT-PCR using primers to amplify a 515 bp TROSPA or a 400 bp
-actin fragment (arrow).
(F) Injection of TROSPA dsRNA selectively knocks down the native TROSPA protein. Guts from nymphal ticks, as described in (E), were
probed with TROSPA or actin antisera in a Western blot. Position of 55 kDa native TROSPA denoted by arrow, whereas migration of 46 kDa
actin is indicated by arrowhead.
(G) Detection of B. burgdorferi, which remained closely associated with gut tissue within TROSPA dsRNA, salp15 dsRNA, or buffer-treated
I. scapularis. Guts isolated from nymphal ticks, as described in (E), were processed for in vivo adherence studies using confocal immunofluores-
cence microscopy. The spirochetes (arrow) were stained with a FITC-labeled goat anti-B. burgdorferi antibody (green), TROSPA was labeled
with a anti-rabbit IgG-Cy5 (blue), and the nuclei of the tick gut epithelial cells were stained with propidium iodide (red). Samples were examined
using the confocal 40 objective lens, and one representative field from each RNAi group is presented as a single image for clarity.
(H) Quantitative assessment (relative number of B. burgdorferi) of the data presented in (G). B. burgdorferi, which remained in direct contact
with tick gut tissue, were enumerated using confocal microscopy. In each experiment, counts were made from at least ten fields from five
separate gut diverticulum. Data are the number of spirochetes per microscopic field from three independent experiments (mean  SE). The
average number of spirochetes/microscopic field in case of TROSPA dsRNA, salp15 dsRNA, and buffer-treated ticks was 11  2 (range,
1–37), 24  4 (range, 7–68), and 27  4 (range, 4–80), respectively. Differences of spirochete number between TROSPA dsRNA-treated group
with either buffer-treated or salp15 dsRNA treated groups were significant, p  0.001. Numbers of B. burgdorferi in buffer treated group
(control) were considered as 100% value.
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were infected with B. burgdorferi N40 (105 spirochetes/mouse, five Folsch, H., Pypaert, M., Schu, P., and Mellman, I. (2001). Distribution
and function of AP-1 clathrin adaptor complexes in polarized epithe-animals/group) for 3 weeks, and preimmune rabbit sera or TROSPA
antisera were administered to groups of mice (250 	l intraperitone- lial cells. J. Cell Biol. 152, 595–606.
ally and 250 	l subcutaneously). Twenty-four hours later, 20 larva Grimm, D., Tilly, K., Byram, R., Stewart, P.E., Krum, J.G., Bueschel,
or ten I. scapularis nymphs were placed on each mouse. The animals D.M., Schwan, T.G., Policastro, P.F., Elias, A.F., and Rosa, P.A.
were again treated with the respective sera on the next day. The (2004). Outer-surface protein C of the Lyme disease spirochete: a
ticks were allowed to feed to repletion and detach from the mice, protein induced in ticks for infection of mammals. Proc. Natl. Acad.
which usually occurred between 72 and 96 hr. Guts from each group Sci. USA 101, 3142–3147.
of nymphs were dissected under a microscope in PBS (20 	l/gut) Guo, B.P., Brown, E.L., Dorward, D.W., Rosenberg, L.C., and Hook,
after intervals of 24 hr until 96 hr following engorgement. Aliquots M. (1998). Decorin-binding adhesins from Borrelia burgdorferi. Mol.
(5 	l) were examined for viable spirochetes under dark-field micros- Microbiol. 30, 711–723.
copy. A few larva or nymphs were subjected to RT-PCR 7 days
Kozak, M. (1987). An analysis of 5-noncoding sequences from 699following engorgement. Selected larva or nymphs from each group
vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125–8148.were also allowed to molt to nymphs or adults.
Malawista, S.E. (2000). Lyme disease. In Arthritis and Allied Condi-Organs from nymphal ticks were prepared for confocal micros-
tions, W.J. Koopman, ed. (Baltimore, MD: Williams and Wilkins),copy as previously described by dissection of gut diverticula in PBS
pp. 2321.(Pal et al., 2001). Briefly, the lumen of each gut diverticulum was
exposed and washed free of luminal contents or unbound spiro- Munderloh, U.G., and Kurtti, T.J. (1995). Cellular and molecular inter-
chetes, placed on silylated glass slides, and fixed with acetone. The relationships between ticks and prokaryotic tick-borne pathogens.
tissues were rinsed twice with PBS and incubated for 30 min in Annu. Rev. Entomol. 40, 221–243.
PBS-T with 5% normal goat serum (NGS) at room temperature. Nadelman, R.B., and Wormser, G.P. (1998). Lyme borreliosis. Lancet
Organs were incubated with an affinity-purified FITC-labeled goat 352, 557–565.
anti-B. burgdorferi antibody (KPL) at a dilution of 1:50 in PBS-T
Narasimhan, S., Montgomery, R.R., DePonte, K., Tschudi, C., Mar-with 5% NGS at room temperature for 1 hr. The samples were
cantonio, N., Anderson, J.F., Sauer, J.R., Cappello, M., Kantor, F.S.,counterstained with propidium iodide (50 	l of a 10 	g/ml solution),
and Fikrig, E. (2004). Disruption of Ixodes scapularis anticoagulationmounted in antifade reagent, and examined by scanning the entire
by using RNA interference. Proc. Natl. Acad. Sci. USA 101, 1141–organ in the confocal microscope.
1146.
Ohnishi, J., Piesman, J., and de Silva, A.M. (2001). Antigenic andRNA Interference
genetic heterogeneity of Borrelia burgdorferi populations transmit-RNA interference techniques of nymphal I. scapularis were detailed
ted by ticks. Proc. Natl. Acad. Sci. USA 98, 670–675.in the Supplemental Experimental Procedures. Generation of dsRNA
and microinjection into nymphal I. scapularis gut were performed Pal, U., de Silva, A.M., Montgomery, R.R., Fish, D., Anguita, J., An-
derson, J.F., Lobet, Y., and Fikrig, E. (2000). Attachment of Borreliaas recently described (Narasimhan et al., 2004; Pal et al., 2004).
burgdorferi within Ixodes scapularis mediated by outer surface pro-
tein A. J. Clin. Invest. 106, 561–569.Statistical Analysis
Results are expressed as the mean standard error (SE). The signifi- Pal, U., Montgomery, R.R., Lusitani, D., Voet, P., Weynants, V., Mala-
cance of the difference between the mean values of the groups was wista, S.E., Lobet, Y., and Fikrig, E. (2001). Inhibition of Borrelia
evaluated by Student’s t test or repeated-measure ANOVA with burgdorferi-tick interactions in vivo by outer surface protein A anti-
the Fisher’s protected least significant difference test with Statview body. J. Immunol. 166, 7398–7403.
software (SAS Institute, Cary, NC). Binding analysis was performed Pal, U., Yang, X., Chen, M., Bockenstedt, L.K., Anderson, J.F., Fla-
using Origin software version 6.0 (OriginLab Corporation, MA). vell, R.A., Norgard, M.V., and Fikrig, E. (2004). OspC facilitates Bor-
relia burgdorferi invasion of Ixodes scapularis salivary glands. J.
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